Damien McDevitt has joined Carlsbad’s Ionis Pharmaceuticals as chief business officer.
McDevitt joins Ionis from Acadia Pharmaceuticals, where he was senior vice president, corporate development. Prior to Acadia, he was at GlaxoSmithKline for more than two decades, where he was instrumental in more than 70 global business development transactions involving multiple therapeutic areas.
In a statement McDevitt cited Ionis’ blockbuster drug Spinraza, two company drug launches this year and readouts from multiple clinical studies in the near term.
Sarah Boyce previously held the position. Earlier this year she became president of Ionis spinout Akcea Pharmaceuticals.
Read more about Ionis in this May San Diego Business Journal company profile.